- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/26 - Radicals substituted by halogen atoms or nitro radicals
Patent holdings for IPC class C07D 213/26
Total number of patents in this class: 218
10-year publication summary
|
20
|
17
|
12
|
14
|
8
|
11
|
15
|
9
|
9
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dow AgroSciences LLC | 1196 |
8 |
| Novartis AG | 10327 |
6 |
| Mycovia Pharmaceuticals, Inc. | 40 |
6 |
| Merck Sharp & Dohme LLC | 3729 |
6 |
| UDC Ireland Limited | 514 |
5 |
| Agc, Inc. | 5337 |
5 |
| Sumitomo Chemical Company, Limited | 9055 |
4 |
| The Regents of the University of Michigan | 4918 |
4 |
| Essilor International (compagnie Generale D'optique) | 2962 |
4 |
| Nankai University | 253 |
4 |
| Rigel Pharmaceuticals, Inc. | 509 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2973 |
4 |
| Corteva Agriscience LLC | 2643 |
4 |
| Bristol-myers Squibb Company | 4811 |
3 |
| Samsung Display Co., Ltd. | 37960 |
3 |
| Daikin Industries, Ltd. | 10401 |
3 |
| FMC Corporation | 811 |
3 |
| Osaka University | 3301 |
3 |
| The United States of America, as represented by the Secretary, Department of Health & Human Services | 217 |
3 |
| Universal Display Corporation | 2042 |
3 |
| Other owners | 133 |